Cargando…
Managing Anticoagulation for COVID-19-Related Lung Transplantation
Autores principales: | Fox, W. Everett, Patel, Janki, Cross, Matthew W., McNeil, John S., Raphael, Jacob, Blank, Randal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
W.B. Saunders
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617652/ https://www.ncbi.nlm.nih.gov/pubmed/36414531 http://dx.doi.org/10.1053/j.jvca.2022.10.022 |
Ejemplares similares
-
Overcoming barriers to integrating direct oral anticoagulants into existing anticoagulation management services
por: Sylvester, Katelyn W., et al.
Publicado: (2018) -
Lung transplantation for Interstitial Lung disease, the experience of an outpatient clinic
por: Jacob, Maria, et al.
Publicado: (2020) -
Management of Obstructive Prosthetic Heart Valve Thrombosis: Thrombolytic Therapy or Anticoagulation?
por: Güner, Ahmet, et al.
Publicado: (2021) -
Anesthetic management of living-donor lung transplantation for end-stage COVID-19 lung failure
por: Shimizu, Satoshi, et al.
Publicado: (2022) -
Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)